Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigator Initiated Clinical Trial on the Tolerance, Safety and Preliminary Efficacy of KSH01-TCRT Injection in Solid Tumor Subjects

NCT05580796 is registered in ClinicalTrials.gov with TCRx Therapeutics Co.Ltd as lead sponsor.

NCT NCT05580796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05580796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigator Initiated Clinical Trial on the Tolerance, Safety and Preliminary Efficacy of KSH01-TCRT Injection in Solid Tumor Subjects
Lead sponsor
TCRx Therapeutics Co.Ltd
Phase
Phase 1
Overall status
Recruiting
Start date
October 11, 2022
Completion date
October 11, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor